Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder, Drug Metabolism and Personalized Therapy, December 2018, De Gruyter,
DOI: 10.1515/dmpt-2018-0019.
You can read the full text:
Contributors
The following have contributed to this page
